Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

: Verified by RoundPaper

FY 2023

Verified NonprofitLast Filed 2023EIN 73-0580274

Oklahoma Medical Research Foundation

Oklahoma City, OKNTEE: H920Founded 1946Website

mission statement

Oklahoma Medical Research Foundation (OMRF) is dedicated to developing a better understanding of and more effective treatments for human disease.

Share this profile

Total Revenue

$132.3M

FY 2023

Program Spending

92.6%

of total expenses

Known Funders

2019–2024 filings

Key Metrics (FY 2023)

The Numbers

$528.8M

Total Assets

$489.5M net

49.07 mo

Operating Reserves

FY 2023

+16%

Revenue Growth

YoY

643

Total Employees

FY 2023

Funding Track Record

Backed by 90 Institutional Funders

$106.4M raised across 264 grants · +$2.2M committed (2019–2024 filings)

Funder Geography

Funders across 19 states (2019–2024 filings)

Institutional Funding by Year

PaidCommittedBoth

Funder	Location	Total Awarded
J A Leta M Chapman Charitable Tr 486002ac2	TULSA, OK	$60,205,142
Leta McFarlin Chapman Memorial Tr 486003ac0	TULSA, OK	$9,296,836
Emory University	Atlanta, GA	$7,981,927
J A Leta M Chapman Tr 10267 486001ac4	TULSA, OK	$7,548,152
The Samuel Roberts Noble Foundation	Ardmore, OK	$3,500,000
American Heart Association Inc	DALLAS, TX	$2,096,395
E L and Thelma Gaylord Foundation	OKLAHOMA CITY, OK	$2,007,500
Lupus Research Alliance Inc	NEW YORK, NY	$1,869,573
Buck Institute for Research on Aging	NOVATO, CA	$1,300,000
The Hardesty Family Foundation Inc	TULSA, OK	$1,064,000

Total tracked: $106,379,111 across 264 grants · +$2,175,000 committed across 9 commitments (2019–2024 filings)

Totals reflect grants as reported on funder tax returns. Timing may not match recipient revenue: funder and recipient fiscal years often differ, and grants paid by a funder in one year may be recognized by the recipient in a different year.

Programs (FY 2023)

What They Do

$45.3M in expenses

Arthritis and Clinical Immunology/Clinical Operations - After being redesignated in 2024 as one of only seven Autoimmunity Centers of Excellence recognized by the National Institutes of Health, OMRF continued to blaze new paths in researching and treating autoimmune diseases. The foundation received a trio of major new federal grants to study these illnesses. Meanwhile, OMRF caregivers treated more than 3,000 patients living with multiple sclerosis, lupus, rheumatoid arthritis and other diseases in which the body turns its immune system against itself.

$10.7M in expenses

Cardiovascular Biology Research Program - Early-career scientists led a watershed year for the study of diseases of the heart, blood and circulatory system. Together, graduate students and postdoctoral fellows in this program earned 11 research grants and fellowships, which could blaze new treatment paths for illnesses ranging from heart attack and stroke to diabetes-related vision loss. Meanwhile, the program's leader, Dr. Lijun Xia, led research that could one day lead to a new drug to treat the pain crises in sickle cell disease. Finally, an experimental therapy born from discoveries in this program began clinical trials in patients with hemophilia, the inherited blood disorder that can be life-threatening.

$9.5M in expenses

Aging and Metabolism Research Program - Drs. Michael Beckstead and Harris Blankenship made a groundbreaking discovery that could one day transform the lives of Alzheimer's patients. In experiments with mice genetically engineered to develop a condition that mimics Alzheimer's disease, they found that dopamine - a brain chemical associated with behavioral rewards - could play a crucial role in causing the deadly, memory-robbing disease. The scientists published their findings in 2024 in the influential scientific journal Nature Communications. "We've at least cracked the surface of something that might slow down this terrible disease," said Beckstead. "With more work, we hope we can make a big difference."

$45.3M in expenses

Other program services include departments such as Cell Cycle and Cancer Biology, Genes and Human Disease, Center for Biomedical Data Sciences and other scientific and research support services.

Financial History